A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)

Clinical trial NCT00090220 · COMPLETED

Trial details

NCT number: NCT00090220
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Healthy Adult Female Participants Prevention Papillomavirus Infection Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18

Start date: 2004-06-16
Primary completion: 2009-05-21
Enrollment: 3819

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.